# Hangzhou China Resources Laotongjun Pharmaceutical Co., Ltd. · 66-41 · CHINA — FDA import alert red lists: firms subject to detention without physical examination

For Hangzhou China Resources Laotongjun Pharmaceutical Co., Ltd. · 66-41 · CHINA, import alert is 66-41; import alert name is Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S; country is CHINA; product is Kangbingdu (Antiviral Oral Solution) | Kangbingdu (Antiviral Oral Solution) | Kangbingdu (Antiviral Oral Solution) | Kangbingdu (Antiviral Oral Solution); product code is 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 58 E - - 99 Antiviral, NEC | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 06/04/2024; address is No. 88 Langyuan Road , Tonglu Economic Development Zone , Hangzhou, Cn-Zj CHINA, verified against its source on 2026-09-16.

- **Firm:** Hangzhou China Resources Laotongjun Pharmaceutical Co., Ltd. _(verified: appears in the quote below)_
- **Import alert:** 66-41
- **Import alert name:** Detention Without Physical Examination of Unapproved New Drugs Promoted In The U.S.
- **Country:** CHINA _(verified: appears in the quote below)_
- **Address:** No. 88 Langyuan Road , Tonglu Economic Development Zone , Hangzhou, Cn-Zj CHINA _(verified: appears in the quote below)_
- **Date published:** 06/04/2024 _(verified: appears in the quote below)_
- **Product code:** 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. | 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. | 58 E - - 99 Antiviral, NEC | 66 V - - 99 Miscellaneous Patent Medicines, Etc. _(verified: each item appears in the quote below)_
- **Product:** Kangbingdu (Antiviral Oral Solution) | Kangbingdu (Antiviral Oral Solution) | Kangbingdu (Antiviral Oral Solution) | Kangbingdu (Antiviral Oral Solution) _(verified: each item appears in the quote below)_
- **FDA notes:** The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its labeling includes claims such as: “Anti-viral oral solution” and “Is used for… cold, and influenza”. | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its labeling includes claims such as: “Anti-viral oral solution” and “Is used for… cold, and influenza”. | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its labeling includes claims such as: “Anti-viral oral solution” and “Is used for… cold, and influenza”. | The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its labeling includes claims such as: “Anti-viral oral solution” and “Is used for… cold, and influenza”. _(verified: each item appears in the quote below)_

## What the source says

> Hangzhou China Resources Laotongjun Pharmaceutical Co., Ltd. Date Published : 06/04/2024 No. 88 Langyuan Road , Tonglu Economic Development Zone , Hangzhou, Cn-Zj CHINA 54 F - - 99 Herbals & Botanicals (not Teas), N.E.C. Date Published: 06/04/2024 Desc: Kangbingdu (Antiviral Oral Solution) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its labeling includes claims such as: “Anti-viral oral solution” and “Is used for… cold, and influenza”. 54 Y - - 99 Vitamin, Mineral, Proteins and Unconventional Dietary Specialities For Humans and Animals, N.E.C. Date Published: 06/04/2024 Desc: Kangbingdu (Antiviral Oral Solution) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its labeling includes claims such as: “Anti-viral oral solution” and “Is used for… cold, and influenza”. 58 E - - 99 Antiviral, NEC Date Published: 06/04/2024 Desc: Kangbingdu (Antiviral Oral Solution) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its labeling includes claims such as: “Anti-viral oral solution” and “Is used for… cold, and influenza”. 66 V - - 99 Miscellaneous Patent Medicines, Etc. Date Published: 06/04/2024 Desc: Kangbingdu (Antiviral Oral Solution) Notes: The product appears to be a new drug within the meaning of Section 201(p) of the Act, without an effective new drug application (NDA) [Unapproved New Drug, Section 505(a)], as its labeling includes claims such as: “Anti-viral oral solution” and “Is used for… cold, and influenza”.

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_190.html

Last verified: 2026-09-16. Review by: 2026-11-15.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).